Real-world retrospective analysis of over 29,000 patients performing INR home monitoring for warfarin therapy shows excellent time in therapeutic range. Point-of-care, home international normalized ...

Please provide your email address to receive an email when new articles are posted on . If I were a patient on long-term warfarin, I would want an international normalized ratio home monitor. It would ...

At-home patient self-monitoring of warfarin therapy yielded similar results to monitoring performed in a clinic setting and randomized trials, particularly among those who self-tested on a weekly ...

Individuals taking warfarin who engaged in weekly patient self-testing (PST) had significant improvement in control of warfarin compared to patients who had variable (1–4 tests per month) self-testing ...

The US Food and Drug Administration (FDA) has concluded that inaccurate results from the point-of-care device used to measure international normalized ratio (INR) values in warfarin-treated patients ...

Warfarin is very effective in preventing recurrent venous thromboembolism but is also associated with a substantial risk of bleeding. After three months of conventional warfarin therapy, a lower dose ...

Potential problems with the point-of-care device used to monitor warfarin in ROCKET AF did not appear to have a meaningful impact on the trial results, an analysis by study investigators shows. The ...

Oral anticoagulation with warfarin requires a relatively individualized therapeutic approach to establish appropriate dosing. It is of the utmost importance to administer correct initial dosing given ...

April 26, 2010 — Influenza vaccination has no significant effect on international normalized ratio (INR) values or weekly doses of warfarin sodium, according to the results of a placebo-controlled, ...

A voluntary recall of certain test strips made by Roche Diagnostics for use with its CoaguChek warfarin anticoagulation meters is now categorized as Class I, the US Food and Drug Administration has ...

Despite the use of antiplatelet agents, usually aspirin, in patients who have had an ischemic stroke, there is still a substantial rate of recurrence. Therefore, we investigated whether warfarin, ...